Skip to main content
Grant Details

Grant Number: 5R01CA172855-05 Interpret this number
Primary Investigator: Kwan, Marilyn
Organization: Kaiser Foundation Research Institute
Project Title: Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors
Fiscal Year: 2018


DESCRIPTION (provided by applicant): Bladder cancer is one of the top ten most common cancers in the U.S., contributing to over 60,000 new cases and 10,000 deaths annually. The majority of cases (70-80%) are diagnosed at early stage (termed "non-muscle invasive"), yet the cancer typically recurs (50-80%), with a subset further progressing to muscle- invasive disease with poor survival. Due to this markedly high recurrence and progression, patients are followed intensively by cystoscopy with repeat transurethral manipulation, making bladder cancer one of the most costly diseases. Cruciferous vegetable intake has been associated with reduced risk of primary bladder cancer and improved survival, which might be partly attributable to their unique phytochemical isothiocyanates (ITCs). Dietary ITCs are promising chemopreventive agents with multi-faceted anti-cancer mechanisms. Our prior in vitro, in vivo, and epidemiologic studies strongly support dietary ITCs and ITC-rich cruciferous vegetables playing a key role in preventing bladder cancer recurrence and progression and improving prognosis. Above all, via metabolic pathways in humans, orally ingested ITCs are rapidly delivered to the bladder and concentrated in the urine, rendering bladder cancer the best target for their anti-cancer activities. This application requests to conduct a new prospective cohort study of 1,811 newly diagnosed non- muscle invasive bladder cancer patients in the Kaiser Permanente Northern California (KPNC) and Southern California (KPSC) Medical Care Programs. Our goal is to comprehensively examine the role of cruciferous vegetable intake, in conjunction with genetic polymorphisms related to ITC metabolism, in potentially reducing disease recurrence and progression, and increasing the efficacy of intravesical treatment. We propose to investigate: 1) the associations between cruciferous vegetable intake and bladder cancer recurrence and progression; 2) the modifying effect of polymorphisms of ITC-metabolizing genes on the associations between cruciferous vegetable intake and bladder cancer recurrence and progression; and 3) the effects of the interactions between cruciferous vegetable intake and therapeutic agents on bladder cancer recurrence and progression. Furthermore, we propose to establish the largest prospective cohort of non-muscle invasive bladder cancer patients with longitudinal questionnaire data and banked biospecimens for further future research of bladder cancer outcomes including survival and quality of life. Bladder cancer is an extremely understudied disease considering its disproportionate high incidence and recurrence, high cost of clinical management, and significant impact on quality of life. The proposed study within one of the largest U.S. integrated health care settings will be the first to investigate the role of dit in recurrence and progression of the disease, with genetic profiles taken into consideration to identify those who will benefit most. Considering the wide availability of cruciferous vegetables in the U.S., this study could have an immediate impact on bladder cancer prognosis.


Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non-muscle-invasive bladder cancer: findings from the Be-Well Study.
Authors: Wang Z. , Kwan M.L. , Haque R. , Goniewicz M. , Pratt R. , Lee V.S. , Roh J.M. , Ergas I.J. , Cannavale K.L. , Loo R.K. , et al. .
Source: The American journal of clinical nutrition, 2023 Jun; 117(6), p. 1110-1120.
EPub date: 2023-04-11.
PMID: 37044209
Related Citations

Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective Cohort.
Authors: Sharma V. , Chamie K. , Schoenberg M. , Lee V.S. , Fero K. , Lec P. , Munneke J.R. , Aaronson D.S. , Kushi L.H. , Quesenberry C.P. , et al. .
Source: Urology, 2023 Mar; 173, p. 134-141.
EPub date: 2022-12-24.
PMID: 36574911
Related Citations

Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study.
Authors: Kwan M.L. , Haque R. , Young-Wolff K.C. , Lee V.S. , Roh J.M. , Ergas I.J. , Wang Z. , Cannavale K.L. , Ambrosone C.B. , Loo R.K. , et al. .
Source: JAMA network open, 2022-11-01; 5(11), p. e2244430.
EPub date: 2022-11-01.
PMID: 36449286
Related Citations

Effects of cooking methods on total isothiocyanate yield from cruciferous vegetables.
Authors: Wang Z. , Kwan M.L. , Pratt R. , Roh J.M. , Kushi L.H. , Danforth K.N. , Zhang Y. , Ambrosone C.B. , Tang L. .
Source: Food science & nutrition, 2020 Oct; 8(10), p. 5673-5682.
EPub date: 2020-09-09.
PMID: 33133569
Related Citations

Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer.
Authors: Kwan M.L. , Garren B. , Nielsen M.E. , Tang L. .
Source: Urologic oncology, 2019 Jun; 37(6), p. 380-386.
EPub date: 2018-04-25.
PMID: 29703514
Related Citations

The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.
Authors: Kwan M.L. , Kushi L.H. , Danforth K.N. , Roh J.M. , Ergas I.J. , Lee V.S. , Cannavale K.L. , Harrison T.N. , Contreras R. , Loo R.K. , et al. .
Source: Cancer causes & control : CCC, 2019 Feb; 30(2), p. 187-193.
EPub date: 2019-01-17.
PMID: 30656539
Related Citations

Perioperative Intravesical Chemotherapy for Patients WithNon-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use.
Authors: Check D.K. , Aaronson D.S. , Nielsen M.E. , Lee V.S. , Ergas I.J. , Roh J.M. , Kushi L.H. , Tang L. , Kwan M.L. .
Source: Urology, 2019 Feb; 124, p. 107-112.
EPub date: 2018-10-23.
PMID: 30359712
Related Citations

Cruciferous vegetables, isothiocyanates, and prevention of bladder cancer.
Authors: Veeranki O.L. , Bhattacharya A. , Tang L. , Marshall J.R. , Zhang Y. .
Source: Current pharmacology reports, 2015 Aug; 1(4), p. 272-282.
PMID: 26273545
Related Citations

Back to Top